The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women
Abstract
BACKGROUND: While high-sensitivity C-reactive protein (hsCRP) is an independent predictor of cardiovascular risk, global risk prediction models incorporating hsCRP have not been developed for clinical use. OBJECTIVE: To develop and compare global cardiovascular risk prediction models with and without hsCRP. DESIGN: Observational cohort study. SETTING: U.S. female health professionals. PARTICIPANTS: Initially healthy nondiabetic women age 45 years and older participating in the Women's Health Study and followed an average of 10 years. MEASUREMENTS: Incident cardiovascular events (myocardial infarction, stroke, coronary revascularization, and cardiovascular death). RESULTS: High-sensitivity CRP made a relative contribution to global risk at least as large as that provided by total, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol individually, but less than that provided by age, smoking, and blood pressure. All global measures of fit improved when hsCRP was included, with likelihood-based measures demonstrating strong preference for models that include hsCRP. With use of 10-year risk categories of 0% to less than 5%, 5% to less than 10%, 10% to less than 20%, and 20% or greater, risk prediction was more accurate in models that included hsCRP, particularly for risk between 5% and 20%. Among women initially classified with risks of 5% to less than 10% and 10% to less than 20% according to the Adult Treatment Panel III covariables, 21% and 19%, respectively, were reclassified into more accurate risk categories. Although addition of hsCRP had minimal effect on the c-statistic (a measure of model discrimination) once age, smoking, and blood pressure were accounted for, the effect was nonetheless greater than that of total, LDL, or HDL cholesterol, suggesting that the c-statistic may be insensitive in evaluating risk prediction models. LIMITATIONS: Data were available only for women. CONCLUSIONS: A global risk prediction model that includes hsCRP improves cardiovascular risk classification in women, particularly among those with a 10-year risk of 5% to 20%. In models that include age, blood pressure, and smoking status, hsCRP improves prediction at least as much as do lipid measures.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CRP has emerged as a particularly stronger independent risk factor for cardiovascular disease than the low-density lipoprotein cholesterol level [13, 33, 34].”
From Exercise as a Mean to Control Low‐Grade Systemic Inflammation (2008) · cites this paper as [33]
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
The Elements of Statistical Learning
Hastie, T., Tibshirani, R., & Friedman, J. (2009) · Springer Series in Statistics · doi:10.1007/978-0-387-84858-7 · Cited by 25,970
The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Research works printed but not linked: 3
- Buring JE, 1992, Journal of Myocardial Ischemia, 4, 27
- Nagelkerke NJ, 1991, Biomka, 78, 691
- Boekholdt SM, 2005, Atherosclerosis
Cited by
Sorted by citations
Items 401–500 of 503
Estratificación de riesgo cardiovascular en la población chilena
Sonia Kunstmann, F., Lira, M. T., Gloria, I. N., Loreto, N.-F., & Grazia, K. R. D. (2012) · Revista Médica Clínica Las Condes · doi:10.1016/s0716-8640(12)70365-6 · Cited by 3
MARCADORES CARDIACOS Y RIESGO CARDIOVASCULAR
David Doron, R., & Marcelo Muñoz, C. (2015) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2015.04.002 · Cited by 3
Cardiovascular Risk Assessment—Where Are We Going?
Wilson, P. W. F. (2008) · Preventive Cardiology · doi:10.1111/j.1751-7141.2008.07770.x · Cited by 3
C-REACTIVE PROTEIN IN HOSPITAL PATIENTS IN A SOUTHWESTERN NIGERIAN COMMUNITY
Ojo, D. A., & Talabi, O. A. (2010) · Journal of Natural Sciences Engineering and Technology · doi:10.51406/jnset.v9i1.1056 · Cited by 3
Use of High-Sensitivity C-Reactive Protein for Risk Assessment
Campbell, C. Y., Musunuru, K., Mora, S., & Blumenthal, R. S. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50017-2 · Cited by 3
McLean, A. S., & Huang, S. (2010) · Biomarkers · doi:10.1002/9780470918562.ch7 · Cited by 3
Predicting stroke outcome: what does the 'stroke prognostocrit level' indicate?
Sacco, R. L. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0345 · Cited by 3
Why Risk Factors Minimally Change the ROC Curve AUCPreprint
Stern, R. H. (2022) · medRxiv · doi:10.1101/2022.02.24.22271481 · Cited by 3
Nonobstructive Coronary Artery Disease in Women: Risk Factors and Noninvasive Diagnostic Assessment
Ferdinand, K. C., & Samson, R. (2019) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2017.0077 · Cited by 2
Vijayalakshmi, S. P., Pramila, K., & Lalitha, R. (2016) · Journal of Medical Sciences and Health · doi:10.46347/jmsh.2016.v02i02.005 · Cited by 2
Kaur, P., Dahiya, R., Kaur, G., Buttar, H. S., Wilson, D. W., & Télessy, I. G. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238273124020010 · Cited by 2
Sürmeli, T., & Duran, H. E. (2024) · Journal of Research in Applied and Basic Medical Sciences · doi:10.61186/rabms.10.2.191 · Cited by 2
Clinical Use of Serum Biomarkers in the Prediction of Cardiovascular Risk
Madjid, M., & Willerson, J. T. (2015) · Cardiovascular medicine · doi:10.1007/978-1-4471-2828-1_2 · Cited by 2
School for Social Care Research
Library, N. J. (2015) · Cited by 2
Statins and Primary Prevention of Cardiovascular Disease in Women
Ijioma, N., & Robinson, J. G. (2013) · American Journal of Lifestyle Medicine · doi:10.1177/1559827613504536 · Cited by 2
Tsai, C.-C., HSIEH, M., Li, A., Chen, P., & Jeng, C. (2013) · Journal of Clinical Nursing · doi:10.1111/jocn.12263 · Cited by 2
Biomarcadores cardíacos: Presente y futuro
Fernández, E., García, C., de la Espriella, R., Castell, C. R. D., & Manzur, F. (2012) · Revista Colombiana de Cardiología · doi:10.1016/s0120-5633(12)70151-1 · Cited by 2
Migraine and Risk of Cardiovascular Disease in Women
Frishman, W. H. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70202-5 · Cited by 2
Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
Gersh, B. J. (2010) · Yearbook of Cardiology · doi:10.1016/s0145-4145(09)79727-8 · Cited by 2
Novel Biomarkers and the Assessment of Cardiovascular Risk
Nambi, V., Brautbar, A., & Ballantyne, C. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1366-4.00005-6 · Cited by 2
Prediction of Cardiovascular Disease
Wilson, P. W. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1366-4.00003-2 · Cited by 2
Mitevska, I. P., Srbinovska, E., Stojanovska, L., Antova, E., Apostolopoulos, V., & Bosevski, M. (2019) · Indian Journal of Nuclear Medicine · doi:10.4103/ijnm.ijnm_152_18 · Cited by 2
Owens, C. D., & Conte, M. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5223-4.00004-4 · Cited by 2
High-Sensitivity C-Reactive Protein
Feldman, D. I., Blumenthal, R. S., & Gluckman, T. J. (2022) · Contemporary cardiology · doi:10.1007/978-3-030-98824-1_17 · Cited by 2
Use of High-Sensitivity C-Reactive Protein for Risk Assessment
Martin, S. S., Johnson, A. E., & Blumenthal, R. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00012-8 · Cited by 2
Sonia Kunstmann, F., & Daniela Gainza, K. (2015) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2015.04.001 · Cited by 2
Myers, G. L. (2010) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 2
Kurth, T., & Glynn, R. J. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.08.003 · Cited by 2
Can Fishing for New Genes Catch Patients at Risk of Coronary Artery Disease?
Emmerich, J., & Ridker, P. M. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.100313 · Cited by 2
Kashani–Sabet, M., Sagebiel, R. W., Joensuu, H., & Miller, J. R. (2013) · PLoS ONE · doi:10.1371/annotation/2db613f0-06cc-47e7-bde2-7c61bc792bb9 · Cited by 2
The case against ApoB and the ApoB:ApoA-I ratio: are they right?
Sniderman, A. D. (2008) · Future Lipidology · doi:10.2217/17460875.3.3.257 · Cited by 2
Aroon, D. (1970) · JAMA · doi:10.1001/jama.1970.03170310052015 · Cited by 2
Pei, F., & Sun, J. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0175-2 · Cited by 1
RetractedRoberts, W. C., Gotto, A. M., Guyton, J. R., LaRosa, J. C., & Viggiani, R. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.09.023 · Cited by 1
The assessment of total cardiovascular risk in hypertensive subjects in primary care
Korhonen, P. E., Vesalainen, R. K., Aarnio, P. T. T., Saaresranta, T., Kautiainen, H., Järvenpää, S. K., & Kantola, I. M. (2010) · Annals of Medicine · doi:10.3109/07853890903521088 · Cited by 1
Villegas, E. C. M. (2011) · Current Hypertension Reviews · doi:10.2174/1573402111107030126 · Cited by 1
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., Johnson, M. R., et al. (2013) · Cited by 1
Ragab, S., & Soliman, M. (2015) · The Egyptian Journal of Haematology · doi:10.4103/1110-1067.170203 · Cited by 1
Subgroup Specific Incremental Value of New Markers for Risk Prediction
Zhou, Q. M., Zheng, Y., & Cai, T. (2013) · Lecture notes in statistics · doi:10.1007/978-1-4614-8981-8_12 · Cited by 1
Primary Prevention and Cardiovascular Risk Assessment in Women
Peterson, L.-A., Freaney, P. M., & Gulati, M. (2022) · Contemporary cardiology · doi:10.1007/978-3-030-98824-1_10 · Cited by 1
Napiórkowska-Baran, K., Doligalska, A., Drozd, M., Czarnowska, M., Łaszczych, D., Dolina, M., Szymczak, B., Schmidt, O., & Bartuzi, Z. (2024) · Healthcare · doi:10.3390/healthcare12191977 · Cited by 2
Jelinek, H. F., Khalaf, K. A., Robinson, C., McDonald, S. P., Butkowski, E., Al-Aubaidy, H. A., & Wild, T. (2015) · Wound Medicine · doi:10.1016/j.wndm.2015.03.003 · Cited by 1
Cardiac imaging and circulating biomarkers for primary prevention in the era of precision medicine
Myhre, P. L., Lyngbakken, M. N., Tveit, S. H., Røsjø, H. R., & Omland, T. (2019) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2019.1660162 · Cited by 1
Lee, J. H., Jeon, Y. J., Kim, H. C., & Jung, S. J. (2021) · Epidemiology and Health · doi:10.4178/epih.e2021044 · Cited by 1
High-Sensitivity C-Reactive Protein
David I. Feldman, Blumenthal, R. S., & Gluckman, T. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88286-6.00008-x · Cited by 1
Ridker, P. M., & Everett, B. M. (2007) · Circulation · doi:10.1161/circulationaha.106.672733 · Cited by 1
Barrios, Y., Lesbia Meertens, G., Morón, A., & Nayka Díaz, W. (2011) · Actualidad Contable FACES · Cited by 1
ADIPOCYTE-DERIVED HORMONES AND CARDIOVASCULAR DISEASE
Eriksson, M. (2010) · DiVA at Umeå University (Umeå University) · Cited by 1
Statistical Evaluation of Markers and Risk Tools for Prostate Cancer Classification and Prediction
Zheng, Y., & Ankerst, D. P. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-281-0_22
Zairagi, A. (2012) · InTech eBooks · doi:10.5772/39018
Vascular Inflammation: A New Horizon in Cardiovascular Risk Assessment
Hegde, V., & Ching, I. (2012) · InTech eBooks · doi:10.5772/32424
Novel Risk Factors for Type II Diabetes Mellitus and Coronary Heart Disease
Dehghan, A. (2010) · EUR Research Repository (Erasmus University Rotterdam)
Assessment of total cardiovascular risk in hypertensive subjects
Korhonen, P. E. (2009) · UTUPub (University of Turku)
Mejía-Montilla, J. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Uso de múltiples biomarcadores para mejorar la predicción de muerte por causas cardiovasculares
Lahera, V. (2010) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(10)70007-3
Application of reclassification measures in comparing risk adjustment models
Mehta, H. B., Mehta, V., & Girman, C. J. (2013) · Value in Health · doi:10.1016/j.jval.2013.03.270
Lin, M.-J., Lin, T.-H., Lin, H.-D., & Lin, C. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.12.095
Hello, C. L., NGuyen, V., & Maiza, D. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70079-1
Williams, B. A. (2013) · Journal of Medical Statistics and Informatics · doi:10.7243/2053-7662-1-5
C-reactive protein as a marker of cardiovascular risk. Chicken, egg or turkey?
Karet, B. (2008) · Primary Care Cardiovascular Journal (PCCJ) · doi:10.3132/pccj.2008.036
Does the yardstick of cardiovascular risk assessment really measure up?
Stuenkel, C. A. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181639ba2
Metabolic syndrome and the development of vascular disease and type 2 diabetes in high-risk patients
Wassink, A. M. J. (2009) · Utrecht University Repository (Utrecht University)
Inflammatory Markers and Genes: Epidemiologic Studies on their Roles in Cardiovascular Disease
Kardys, I. (2007) · EUR Research Repository (Erasmus University Rotterdam)
Coronary artery calcification and cardiovascular risk prediction
Elias‐Smale, S. E. (2012) · RePub (Erasmus University Rotterdam)
CRP’s Predictive Usefulness in Women
Gore, J. M. (2006) · Journal watch · doi:10.1056/jc200608090000002
Novel aspects of cardiovascular biomarkers in myocardial infarction and obstructive sleep apnea
Hall, T. S. (2015) · NORA - Norwegian Open Research Archives
Gutiérrez, M. D. C. R., Correa, M. A., Martínez, O. F., Ríos, I. G., & Savón, K. G. (2013) · Revista de Medicina Isla de la Juventud
ReviewArticle Exercise as a Mean to Control Low-Grade Systemic Inflammation
Mathur, N., & Pedersen, B. K. (2008)
MARCADORES CARDIACOS Y RIESGO CARDIOVASCULAR
Markers, C. (2016)
Biomarcadores cardíacos: presente y futuro Cardiac biomarkers: present and future
Fernández, E., García, C. F., de la Espriella, R., Dueñas, C. R., & Manzur, F. (2012) · DOAJ (DOAJ: Directory of Open Access Journals)
C-Reactive Protein: Not Ready for Population-Wide CVD Risk Assessment
Moloo, J., Saitz, R., FACP., F., & Fasam (2006) · Journal watch · doi:10.1056/jw200607270000001
8. Recent Development of Laboratory Test for Circulatory System
Daimon, M. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.3160
Metabolic Profiles—Based on the 2013 Prevention Guidelines
Stone, N. J., Wilkins, J. T., & Kazmi, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-24687-1_9
Prevention of Ischemic Heart Disease in Women
Orakzai, R. H., SHUFELT, C. L., Shaw, L. J., & Merz, C. N. B. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1366-4.00024-x
Atherosclerosis: Basic Principles and Medical Management
O’Connell, J. B., & Bath, J. (2011) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814317788_0001
Metabolic side effects and risk of cardiovascular disease
Meyer, J. M., GOFF, D. C., & McEvoy, J. P. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511712265.011
Evaluation of pulse wave analysis to assess coronary artery disease
Kotecha, D. (2010) · Spiral (Imperial College London) · doi:10.25560/5650
Fernandes, M. B. R. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2016.tde-01122015-104554
Badade, Z. G., Guddetwar, S. G., Bhale, D. V., Talib, S., & Badade, V. (2020) · MGM Journal of Medical Sciences · doi:10.4103/mgmj.mgmj_41_20
Is the new model better? One metric says yes, but the other says no. Which metric do I use?Preprint
Zhou, Q. M., Lu, Z., Brooke, R. J., Hudson, M. M., & Yuan, Y. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2010.09822
Outcomes and Procedural Considerations for Women Undergoing PCI
Balinda, I. G., Mathenge, N., & Schmidt, A. C. S. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-020-00888-w
Noninvasive Diagnosis of Coronary Artery Disease in Women
Zaręba, K. M., & Mieszczanska, H. Z. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5517-1_4
Zaremba, E. H., & Смалюх, О. В. (2014) · Bukovinian Medical Herald · doi:10.24061/2413-0737.xviii.4.72.2014.226
(2018) · Wiley eBooks · doi:10.1002/9781118829875.refs
Weeks, D. E. (2007) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1097323.553358
Cauci, S., Francescato, M. P., Colannino, C., Barbina, M., Barbina, G., & Xodo, S. (2020) · doi:10.21203/rs.3.rs-27814/v1
Is high-sensitivity CRP assay useful in predictive models for cardiovascular risk?
(2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0287
Brkić, M., Đekić, D., Jovanić, J., Topić, G., Grbić, A., & Šutilović, T. (2022) · Scripta Medica · doi:10.5937/scriptamed53-36711
HDL or hs-CRP: The Prognostic Conundrum in Acute Coronary Syndrome
Gosavi, S., Chekuri, M., Prabhu, M. M., Ramachandran, P., Kumar, B. R., Suvarna, R., & Biswas, M. (2024) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-024-01282-0
Luxama, J. W., & Knowles, J. W. (2025) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.125.005126
Cardiovascular risk prediction in Central and Eastern Europe and former Soviet Union
Vikhireva, O. (2012) · UCL Discovery (University College London)
Leoce, N., Jin, Z., Kehm, R. D., Roh, J. M., Laurent, C. A., Kushi, L. H., & Terry, M. B. (2021) · Figshare · doi:10.6084/m9.figshare.16689689
Zhou, Q. M., Lu, Z., Brooke, R. J., Hudson, M. M., & Yuan, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14984967
Metadata
- Authors
- Cook, N. R., Buring, J. E., & Ridker, P. M.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2006-07-04
- Volume
- 145
- Issue
- 1
- Pages
- 21-29
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2100083473
- Cited by
- 504
- References
- 50
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 10 · 2022: 9 · 2021: 11 · 2020: 7 · 2019: 13 · 2018: 14 · 2017: 9 · 2016: 19 · 2015: 23 · 2014: 21 · 2013: 31 · 2012: 35
- FWCI
- 58.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCLA - Biblioteca de Ciencias de la Salud (submittedVersion)
- Funders
- National Institutes of Health (5r01hl043851-10)
- National Heart, Lung, and Blood Institute (HL43851)
- National Cancer Institute (CA-47988, R01CA047988)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- high-sensitivity C-reactive protein, cardiovascular risk prediction, women, 10-year cardiovascular risk, risk reclassification, model discrimination, concordance index, myocardial infarction, stroke, cardiovascular mortality, Women's Health Study
- MeSH terms
- Age Factors, Blood Pressure, C-Reactive Protein, Cardiovascular Diseases, Female, Humans, Lipids, Middle Aged, Smoking, United States, Cohort Studies, Biomarkers, Proportional Hazards Models, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review